Hidradenitis Suppurativa

Using GLP-1 Agonists in Dermatology
Using GLP-1 Agonists in DermatologyThe weight loss benefits of GLP-1 agonists have long been established, yet could these drugs have a secondary anti-inflammatory impact? Steven Daveluy, MD, FAAD, director of the Wayne State Dermatology Residency Program, gives the latest in GLP-1s in the treatment of hidradenitis suppurativa (HS) and psoriasis, in this Next Steps in Derm video interview, conducted in partnership with the ODAC Derm …
Using GLP-1 Agonists in Dermatology
From the SOCU Poster Hall | Systemic Therapies for Pediatric Hidradenitis Suppurativa
hidradenitis suppurativa (HS)Clinicians treating adults with hidradenitis suppurativa (HS) can use a variety of strategies, from topical and oral medications, to deroofing and laser therapy, as research supports their use. However, choosing an appropriate treatment isn’t as easy when the patient is a developing child. Data on the long-term safety of systemic medications for HS in children isn’t well known. Yet treating pe …
hidradenitis suppurativa (HS)
From the ODAC Poster Hall | Biologic Adherence in Children
Biologic Adherence in ChildrenChildren with dermatologic conditions, ranging from eczema to psoriasis to hidradenitis suppurativa, are benefitting from advances in biologic therapy with several FDA-approved treatment options. However, real-life clinical experience reveals biologic therapy is not always initiated when prescribed. In addition, even when biologic therapy is initiated, adherence is often not maintained. Therefore, …
Biologic Adherence in Children
JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
Patient Buzz Series: Anti-Sunscreen Movement
sunscreenAnother summer means another season for dermatologists in battling sunscreen misinformation, which is a tougher job nowadays thanks to social media. The anti-sunscreen movement, as chronicled by CBS News, is especially influencing young people. Dermatologists are responding by trying to set the record straight on the safety of sunscreen ingredients and the benefits of wearing sunscreen. Dermatolog …
sunscreen